Search Results 551-560 of 20290 for Incidence

  1. Von willebrand factor recombinant (intravenous route) - Side effects & dosage - Mayo Clinic

    Incidence not known. Back pain; blurred vision; burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings; chest tightness ...

  2. Using research to guide treatment of recalcitrant chronic rhinosinusitis in patients who are immunocompromised - Mayo Clinic

    "Our research has given us a stronger understanding of the incidence of recalcitrant CRS, especially in transplant patients," says Dr. Donaldson. "If we ...

  3. Cancer Clinical Trials - Medical Professionals

    The purpose of this study is to assess the 36-month incidence of pelvic/non-vaginal recurrence among patients with surgical stage I intermediate-risk ...

  4. Atrasentan (oral route) - Side effects & dosage - Mayo Clinic

    Incidence not known. Clay colored stools; dark urine; decrease sperm count; decreased appetite; fever; headache; itching, skin rash; loss of appetite; nausea ...

  5. Resmetirom (oral route) - Side effects & dosage - Mayo Clinic

    Incidence not known. Bloating; dark urine; gaseous stomach pain; indigestion; loss of appetite; pains in the stomach, side, or abdomen, possibly radiating to ...

  6. Fosnetupitant/palonosetron (intravenous route) - Side effects & uses - Mayo Clinic

    Incidence not known. Agitation; confusion; cough or hoarseness; dizziness; fast heartbeat; fever; hearing or seeing things that are not there; hives, itching, ...

  7. Cardiovascular Medicine - Clinical trials

    ... incidence of sudden cardiac death. Predictive Role of Non-Invasive Glucose Assessment During Pregnancy. Rochester, Minn. This study aims to determine the ...

  8. Zenocutuzumab-zbco (intravenous route) - Side effects & uses - Mayo Clinic

    Incidence not known. Decreased urine output; dilated neck veins; general feeling of discomfort or illness; irregular heartbeat; swelling of face, fingers, feet ...

  9. Examining the impact of endoscopic resection approach on intestinal metaplasia and dysplasia recurrence after complete remission: EMR versus ESD - Mayo Clinic

    Incidence of any BE recurrence associated with the two ER techniques: 15.7 for EMR and 17.3 for ESD per 100 patient-years. · Incidence of dysplastic BE ...

  10. A Study to Reduce Cardiomyopathy in Breast Cancer Patients Being Treated With Trastuzumab - Mayo Clinic

    The purpose of this study is to evaluate different strategies of cardiovascular therapy with carvedilol aiming to reduce the incidence of heart function ...